医学博士，副教授，大连医科大学硕士研究生导师，现任大连医科大学附属第一医院消化科副主任。留学美国耶鲁大学医学院，先后主持国家自然科学基金、辽宁省教育厅科研基金在内的多项科研项目；近5年先后在国内外知名期刊发表数十篇论著，其中SCI收录论文近10篇。致力于自身免疫性肝病、非酒精性脂肪性肝病及肠肝循环的基础与临床研究，相关研究成果获大连市科技进步二等奖、辽宁省医学科技进步三等奖。

科研立项：

（1）主持辽宁省教育厅科研项目（L2013339）：肠粘膜屏障在非酒精性脂肪肝发病机制中的作用；

（2）主持国家自然科学基金项目（81500402）：肠道CCR9/CCL25信号通路对NAFLD中肠道免疫屏障功能的影响及机制研究。

近年发表的SCI论著：

(1) Jian Bi, Kang Sun, Hao Wu, Xiuli Chen, Haiying Tang, Jingwei Mao (corresponding author), PPARγ alleviated hepatocyte steatosis through reducing SOCS3 by inhibiting JAK2/STAT3 pathway. Biochemical and Biophysical Research Communications, 2018, 1037-1044.

(2) Mao JW, Tang HY, Zhao T, Tan XY, Bi J, Wang BY, Wang YD, Intestinal mucosal barrier dysfunction participates in the progress of nonalcoholic fatty liver disease. Int J Clin Exp Pathol, 2015, 8(4): 3648-3658.

(3) Mao JW, Huang YS, Tang HY, Bi J, Liu YF, Wang YD, Flt3/Flt3L participates in the process of regulating dendritic cells and regulatory T cells in DSS-induced colitis. Gastroenterol Res Pract, 2014, 2014: 483578.

(4) Mao JW, Tang HY, Wang YD, Influence of Rosiglitazone on the Expression of PPARγ, NF-κB, and TNF-α in Rat Model of Ulcerative Colitis, Gastroenterol Res Pract, 2012, 2012: 845672.

(5) Mao JW, Tang HY, Tan XY, Wang YD, Effect of Etiasa on the expression of matrix metalloproteinase-2 and tumor necrosis factor-α in a rat model of ulcerative colitis. Mol Med Rep, 2012, 6(5): 996-1000.

(6) Mao JW, He XM, Tang HY, Wang YD, Protective role of metalloproteinase inhibitor (AE-941) on ulcerative colitis in rats, World J Gastroenterol, 2012, 18(47): 7063-7069.